Whether you work directly in quality assurance, in the broader health care and bioscience industries, or are just looking to learn more about this growing field, you’ll want to listen in on a new locally produced podcast.
She’s a scientist, a breast cancer survivor and now the inventor of a potentially game-changing test for cancer thanks to collaborations that show how far bioscience in Sioux Falls has come.
Inanovate Inc., a life science company specializing in the development of blood tests for cancer and autoimmune diseases, has secured an initial closing of $3.1 million in its latest financing round.
A Sioux Falls biotech startup is one of 20 finalists to become the “Buzz of BIO” at the international organization’s June convention.
A blood test developed by a Sanford Research scientist that uses a patient’s own immune system to help detect breast cancer has been licensed to Inanovate, a medical technology company specializing in screening and analysis of proteins.
Biotech company Inanovate Inc. has named Sioux Falls its official headquarters and anticipates its operations in the city will increase in next two years.
